JP2024014994A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024014994A5 JP2024014994A5 JP2023197141A JP2023197141A JP2024014994A5 JP 2024014994 A5 JP2024014994 A5 JP 2024014994A5 JP 2023197141 A JP2023197141 A JP 2023197141A JP 2023197141 A JP2023197141 A JP 2023197141A JP 2024014994 A5 JP2024014994 A5 JP 2024014994A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- pharmaceutical composition
- following ingredients
- solvate
- pemafibrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 9
- 239000004615 ingredient Substances 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- ZHKNLJLMDFQVHJ-RUZDIDTESA-N (2r)-2-[3-[[1,3-benzoxazol-2-yl-[3-(4-methoxyphenoxy)propyl]amino]methyl]phenoxy]butanoic acid Chemical compound CC[C@H](C(O)=O)OC1=CC=CC(CN(CCCOC=2C=CC(OC)=CC=2)C=2OC3=CC=CC=C3N=2)=C1 ZHKNLJLMDFQVHJ-RUZDIDTESA-N 0.000 claims 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 4
- 229950009401 pemafibrate Drugs 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 239000012453 solvate Substances 0.000 claims 4
- 150000001298 alcohols Chemical class 0.000 claims 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 3
- 229960003511 macrogol Drugs 0.000 claims 3
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 claims 3
- 229920001451 polypropylene glycol Polymers 0.000 claims 3
- 238000000034 method Methods 0.000 claims 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical class O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 claims 2
- 239000003826 tablet Substances 0.000 claims 2
- 239000002775 capsule Substances 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 239000007941 film coated tablet Substances 0.000 claims 1
- 239000007888 film coating Substances 0.000 claims 1
- 238000009501 film coating Methods 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 239000010410 layer Substances 0.000 claims 1
- 239000006187 pill Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 235000012239 silicon dioxide Nutrition 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 239000007909 solid dosage form Substances 0.000 claims 1
- 230000000087 stabilizing effect Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017128683 | 2017-06-30 | ||
| JP2017128683 | 2017-06-30 | ||
| PCT/JP2018/024883 WO2019004448A1 (ja) | 2017-06-30 | 2018-06-29 | 医薬組成物 |
| JP2019527071A JP7007379B2 (ja) | 2017-06-30 | 2018-06-29 | 医薬組成物 |
| JP2022000971A JP2022033328A (ja) | 2017-06-30 | 2022-01-06 | 医薬組成物（２） |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022000971A Division JP2022033328A (ja) | 2017-06-30 | 2022-01-06 | 医薬組成物（２） |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024014994A JP2024014994A (ja) | 2024-02-01 |
| JP2024014994A5 true JP2024014994A5 (enExample) | 2024-02-08 |
Family
ID=64741597
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019527071A Active JP7007379B2 (ja) | 2017-06-30 | 2018-06-29 | 医薬組成物 |
| JP2018126046A Pending JP2019011323A (ja) | 2017-06-30 | 2018-07-02 | 医薬組成物 |
| JP2022000971A Pending JP2022033328A (ja) | 2017-06-30 | 2022-01-06 | 医薬組成物（２） |
| JP2023197141A Pending JP2024014994A (ja) | 2017-06-30 | 2023-11-21 | 医薬組成物（３） |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019527071A Active JP7007379B2 (ja) | 2017-06-30 | 2018-06-29 | 医薬組成物 |
| JP2018126046A Pending JP2019011323A (ja) | 2017-06-30 | 2018-07-02 | 医薬組成物 |
| JP2022000971A Pending JP2022033328A (ja) | 2017-06-30 | 2022-01-06 | 医薬組成物（２） |
Country Status (3)
| Country | Link |
|---|---|
| US (2) | US20200121648A1 (enExample) |
| JP (4) | JP7007379B2 (enExample) |
| WO (1) | WO2019004448A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20200121648A1 (en) * | 2017-06-30 | 2020-04-23 | Kowa Company, Ltd. | Pharmaceutical composition |
| US20220096443A1 (en) * | 2018-12-27 | 2022-03-31 | Kowa Company, Ltd. | Pharmaceutical composition |
| US20220054458A1 (en) * | 2018-12-27 | 2022-02-24 | Kowa Company, Ltd. | Pharmaceutical preparation |
| WO2020138407A1 (ja) * | 2018-12-27 | 2020-07-02 | 興和株式会社 | 医薬品 |
| JP2022013875A (ja) * | 2020-06-30 | 2022-01-18 | 興和株式会社 | 医薬組成物 |
| JP2022023005A (ja) * | 2020-06-30 | 2022-02-07 | 興和株式会社 | 医薬品 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL104192A (en) * | 1992-02-17 | 1998-01-04 | Siegfried Ag Pharma | Pharmaceutical dosage forms having prolonged release rate of zero order of the active ingredient |
| CA2535749C (en) | 2003-09-03 | 2011-11-01 | Kowa Co., Ltd. | Ppar activating compound and pharmaceutical composition containing same |
| KR20080096779A (ko) * | 2006-01-20 | 2008-11-03 | 다이닛본 스미토모 세이야꾸 가부시끼가이샤 | 신규 필름 코팅정 |
| EP2902025B1 (en) * | 2012-09-27 | 2019-08-07 | Kowa Company Ltd. | Therapeutic agent for dyslipidemia |
| TWI696462B (zh) | 2013-07-10 | 2020-06-21 | 日商興和股份有限公司 | 非酒精性脂肪性肝疾病治療劑 |
| GB201319791D0 (en) | 2013-11-08 | 2013-12-25 | Sigmoid Pharma Ltd | Formulations |
| EP3120871B1 (en) | 2014-03-18 | 2023-06-28 | Takeda Pharmaceutical Company Limited | Solid dispersion |
| JP2015218322A (ja) | 2014-05-21 | 2015-12-07 | 旭化成ケミカルズ株式会社 | 微小澱粉粒子及びその製造方法 |
| AU2016272089B2 (en) * | 2015-06-03 | 2021-02-18 | Triastek, Inc. | Dosage forms and use thereof |
| US20200121648A1 (en) * | 2017-06-30 | 2020-04-23 | Kowa Company, Ltd. | Pharmaceutical composition |
-
2018
- 2018-06-29 US US16/626,770 patent/US20200121648A1/en not_active Abandoned
- 2018-06-29 JP JP2019527071A patent/JP7007379B2/ja active Active
- 2018-06-29 WO PCT/JP2018/024883 patent/WO2019004448A1/ja not_active Ceased
- 2018-07-02 JP JP2018126046A patent/JP2019011323A/ja active Pending
-
2022
- 2022-01-06 JP JP2022000971A patent/JP2022033328A/ja active Pending
-
2023
- 2023-09-11 US US18/244,628 patent/US20230414578A1/en active Pending
- 2023-11-21 JP JP2023197141A patent/JP2024014994A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024014994A5 (enExample) | ||
| JP6105761B2 (ja) | 腸溶性被覆されたマルチ粒子徐放性ペパーミントオイル組成物及び関連方法 | |
| JP5911927B2 (ja) | 併用治療のための錠剤 | |
| JP2016518452A5 (enExample) | ||
| JP2010518822A (ja) | ビタミンおよびミネラル補助食品における改善された安定性 | |
| SA112330689B1 (ar) | صيغة كبسولات تشتمل على مونتليوكاست وليڤوستيريزين | |
| JP7074231B2 (ja) | 固形製剤 | |
| KR20180077246A (ko) | 최적화된 고용량 메살라진-포함 정제 | |
| JP2017071605A5 (enExample) | ||
| CA2764172A1 (en) | A thrombin receptor antagonist and clopidogrel fixed dose tablet | |
| JP6160263B2 (ja) | ロキソプロフェン含有医薬組成物 | |
| JP4387192B2 (ja) | Ｓ−アデノシルメチオニンを含む錠剤の調製方法 | |
| JP6159268B2 (ja) | イブプロフェン及びトラネキサム酸を含有するフィルムコーティング製剤 | |
| JPWO2020178878A5 (enExample) | ||
| KR20080096779A (ko) | 신규 필름 코팅정 | |
| JP7541319B2 (ja) | 吸湿性成分を含むコーティング錠 | |
| JP2006511543A (ja) | 安定なトピラメート製剤 | |
| KR101801064B1 (ko) | 위장질환 치료용 삼중층 정제 | |
| WO2006132360A1 (ja) | 糖衣製剤 | |
| JP2020121776A (ja) | エソメプラゾール製剤の乾燥剤包装体 | |
| JP2007521327A (ja) | デスモプレシンを含有するブリスターパック及び固形製剤 | |
| JP6114573B2 (ja) | ロキソプロフェンナトリウムと制酸剤を含有する固形製剤 | |
| EP2915528A1 (en) | Vildagliptin formulation process under inert gas atmosphere | |
| WO2020138407A1 (ja) | 医薬品 | |
| TWI753097B (zh) | 口服甲狀腺治療劑 |